Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment

Título:

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment

Autor:

Fabiana Resende Rodrigues

Ano:

2021

DOI:

10.2147/bctt.s287320

Revista:

Breast Cancer: Targets and Therapy

ISSN:

11791314

Tags:

immunohistochemistry

Home:

[doi:10.2147/bctt.s287320]

Idioma:

Inglês

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

Human epidermal growth factor receptor 2 fluorescence in situ hybridization and P57KIP2 immunohistochemistry using tissue microarray: Improving histopathological subtyping of hydatidiform mole

O Possível Envolvimento do HPV no Câncer de Mama

Does the sequence of anthracycline and taxane matter? The NeoSAMBA trial

O decréscimo vertiginoso das autópsias em um hospital universitário do Brasil nos últimos 20 anos

COX-2 Expression in Breast Cancer and Impact on Survival Outcomes

Mastectomy in the era of implant-based reconstruction: Should we be removing the pectoralis fascia?

The prevalence and prognostic impact of tumor-infiltrating lymphocytes in uterine carcinosarcoma

Traço falcêmico como apresentação clínica de insuficiência hepática aguda

A Standardized Protocol for Radical Mastectomy Specimens at Hospital Universitario Antonio Pedro - Niteroi - Brazil: An Anatomopathological Perspective

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer